Imugene will forge ahead with a planned pivotal US trial for its blood cancer therapy Azer-cel, having recorded more ‘complete responses’ in its phase 1b study.

Money Week with James Willis 💰📈🎙️ - 13 February 2026
50:34

"European welfare state": new warning on government spending 💲📃🚨
12:32

Money News with James Willis 💵📊📻 - Thursday 12th February
38:45